17Dec
Related Posts
25Mar
Encouraging results for Immutep’s cancer therapies
25 Mar 2024 - Immutep Limited (ASX:IMM) CEO and Executive Director Marc Voigt provides an update on the company's pipeline of clinical trials, focusing on results in head and neck cancer, lung cancer and breast cancer.
Read More
11Jun
Calima Energy (ASX:CE1) – high-margin oil and gas producer
10 Jun 2021 - Calima Energy Limited (ASX:CE1) Executive Chairman Glenn Whiddon provides an update on production at the company's projects in British Columbia and its plans for an active, low-risk drilling program developing proven reserves.
Read More
13Jul
Dragonfly Biosciences discusses plans to list on ASX
12 Jul 2023 - Regan Saveall, CEO of leading UK CBD company Dragonfly Biosciences, discusses the company and its plans to list on the ASX in August.
Read More
05Feb
The future of long-range wi-fi: How Morse Micro is revolutionising connectivity
05 Feb 2025 - CEO Andrew Terry discusses long-range wi-fi, semiconductor challenges, and the future of IoT connectivity.
Read More
02Oct
Noxopharm looks at treating prostate cancer with Veyonda® in the LuPIN trial
02 Oct 2019 - Noxopharm Limited (ASX:NOX) Founder and Executive Chairman, Dr Graham Kelly, discusses early results on the use of Noxopharm's lead drug candidate, Veyonda, for the treatment of prostate cancer.
Read More
19Apr
Market update with Shaw and Partners, April 2024
19 Apr 2024 - Shaw and Partners Chief Investment Office Martin Crabb discusses strategies for investing in the current volatile market conditions.
Read More
17Feb
Market update with Shaw and Partners, February 2023
17 Feb 2023 - Shaw and Partners Chief Investment Officer Martin Crabb discusses financial conditions, the outlook for growth, central bank monetary policy, and what this means for portfolio construction.
Read More
29Jul
INOVIQ (ASX:IIQ) discusses US milestones
29 Jul 2022 - INOVIQ Limited (ASX:IIQ) CEO Dr Leearne Hinch discusses recent key announcements, including the appointment of a US sales team, the securing of a US patent, quarterly results, and the year ahead.
Read More
14Sep
icetana locks in a new client, with talks of expanding using emerging AI capabilities
Paul Sanger sits down with Matt Macfarlane from icetana: Discussing a new hardware deal, AI-capable hardware, and plans of expansion in the future.
Read More
08Aug
WT Financial Group (ASX:WTL) FY2023 full-year indicative results
08 Aug 2023 - WT Financial Group Limited (ASX:WTL) Managing Director Keith Cullen discusses drivers of profitability, the effect of lower adviser numbers in the industry and opportunities moving forward.
Read More